A case of seriously sore back after Denosumab discontinuation

被引：0
|
作者：
Lo, Yu-Chin [1 ]
Sinha, Ashim [1 ]
McLean, Anna [1 ]
Ganda, Kirtan [2 ]
机构：
[1] Queensland Hlth, Cairns North, Qld, Australia
[2] Concord Hosp, Endocrine Unit, Sydney, NSW, Australia
来源：
CLINICAL ENDOCRINOLOGY | 2018年 / 89卷
关键词：
POSTMENOPAUSAL WOMEN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
244
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [31] Second rebound-associated vertebral fractures after denosumab discontinuation
    Niimi, Rui
    Kono, Toshibumi
    Nishihara, Atsushi
    Hasegawa, Masahiro
    Kono, Toshihiko
    Sudo, Akihiro
    ARCHIVES OF OSTEOPOROSIS, 2020, 15 (01)
  • [32] Evolution of turnover bone markers after denosumab discontinuation: a preliminary study
    Stoll, D.
    Hans, D.
    Rodriguez, Gonzalez E.
    Lamy, O.
    Aubry-Rozier, B.
    SWISS MEDICAL WEEKLY, 2017, 147 : 5S - 5S
  • [33] DenosumabMultiple vertebral fractures following discontinuation of denosumab: 12 case reports
    Reactions Weekly, 2021, 1867 (1) : 150 - 150
  • [34] Progression of multiple vertebral fractures after denosumab discontinuation under treatment with romosozumab. A case-report
    Krikelis, Michail
    Gazi, Susana
    Trovas, Georgios
    Makris, Konstantinos
    Chronopoulos, Efstathios
    Tournis, Symeon
    JOINT BONE SPINE, 2024, 91 (05)
  • [35] Certainties and Uncertainties About Denosumab Discontinuation
    Tsourdi, Elena
    Zillikens, M. Carola
    CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (01) : 1 - 4
  • [36] Certainties and Uncertainties About Denosumab Discontinuation
    Elena Tsourdi
    M. Carola Zillikens
    Calcified Tissue International, 2018, 103 : 1 - 4
  • [37] Soluble Buffered Alendronate After Denosumab Discontinuation in Erosive Hand OA Patients
    Vanhaverbeke, Tine
    Elewaut, Dirk
    Wittoek, Ruth
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2320 - 2321
  • [38] Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis
    R. Niimi
    T. Kono
    A. Nishihara
    M. Hasegawa
    T. Kono
    A. Sudo
    Osteoporosis International, 2018, 29 : 769 - 772
  • [39] Discontinuation of denosumab in men with prostate cancer
    Anne Sophie Sølling
    Torben Harsløf
    Helle Kongsbak Brockstedt
    Bente Langdahl
    Osteoporosis International, 2023, 34 : 291 - 297
  • [40] Bisphosphonates or denosumab discontinuation and risk of fractures
    Anastasilakis, Athanasios D.
    Yavropoulou, Maria P.
    Makras, Polyzois
    MATURITAS, 2017, 102 : 75 - 75
12345